NCT07698080
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Hemolytic, +19 more
- Locations
-
Not specified
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,146 public trials
2,034 recruiting studies
Lymphoproliferative Disorders trial results
Not yet recruiting
A Study of Polatuzumab Vedotin and Glofitamab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Within 12 Months After R-CHOP
NCT07702851
- Conditions
- Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
- Locations
-
Not specified
Not yet recruiting
HDM2005 Combination Therapy in Relapsed/Refractory Mantle Cell Lymphoma
NCT07697339
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
Not specified
Not yet recruiting
Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT
NCT07254793
- Conditions
- Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Acute Undifferentiated Leukemia (AUL), +31 more
- Locations
-
- The University of Arizona Cancer Center Tucson, Arizona, United States
Not yet recruiting
Testing Mosunetuzumab Alone, With Zanubrutinib, or With Polatuzumab Vedotin for Treating Marginal Zone Lymphoma That Came Back or Didn't Get Better With Treatment
NCT07638722
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
- Locations
-
Not specified
Not yet recruiting
A Study of Glofitamab Plus GemOx Compared With Standard of Care in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT07599423
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Not yet recruiting
Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers
NCT07696169
- Conditions
- AIDS, AIDS-Related Malignancy, Acquired Immunodeficiency Syndrome, +61 more
- Locations
-
Not specified
Not yet recruiting
Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma
NCT07695740
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Beijing Chao-yang Hospital, Capital Medical University Beijing, Beijing Municipality, China
Not yet recruiting
Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia
NCT07696481
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Department of Hematology, Zhujiang Hospital, Southern Medical University Guangzhou, Guangdong, China
Not yet recruiting
Real-World Study of Bispecific Antibody in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
NCT07695896
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Henan Cancer Hospital Zhengzhou, Henan, China